Biogen-backed Duchenne muscular dystrophy (DMD) treatment developer Solid Biosciences has filed to raise up to $100m.

LexinFintech, the instalment buying platform operator backed by Bertelsmann, JD.com and Taikang, had initially targeted $500m in the offering.

Broadband software provider Casa Systems, backed by Liberty Global Ventures, has gone public in a downgraded initial public offering.

University of Minnesota spinout Calyxt has entered the public markets in a flotation that resulted in the share price climbing from $8 to $11.25 on the first day of trading.

Video advertising software developer Mirriad aims to raise $35m in a London initial public offering that will score exits for Unilever, STV and Zee Entertainment.

University of Surrey in-video advertising spinout Mirriad is set to raise $35m in an initial public offering at a market cap of $84.4m.

Quanterix, a digital immunoassay developer spun out of Tufts University, has raised $64.1m in its initial public offering.

Quanterix, a digital immunoassay developer backed by BioMerieux and Stratec, has raised $64.1m in its initial public offering.

Queen's University spinout Fusion Antibodies is targeting $7.4m in proceeds in an IPO that will provide an exit to Qubis and Invest NI.

Bertelsmann and Sumitomo are set to score exits as marketing technology producer iClick Interactive seeks to raise $53m when it floats.